Precision Cardiovascular Appoints Matthew I. Mace to Board of Directors, Bolstering Clinical and Regulatory Leadership

LONDON, Feb. 13, 2025 /PRNewswire/ -- Precision Cardiovascular (PCV), an innovator in next-generation cardiac health solutions, today announced the appointment of Matthew I. Mace, B.Sc., AHCS-accredited Clinical Physiologist and seasoned medtech strategist, to its Board of Directors....